Journal
VACCINE
Volume 28, Issue 46, Pages 7389-7395Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.09.009
Keywords
Immunization; Surveillance; Travel medicine
Categories
Funding
- Centers for Disease Control and Prevention
- Sanofi-Pasteur
- Schering Plough
- Roche
- Novartis
- MSD
- Pfizer
- GlaxoSmithKline
- MRC [G0701652] Funding Source: UKRI
Ask authors/readers for more resources
Vaccine preventable diseases (VPDs) threaten international travelers but little is known about their epidemiology in this group We analyzed records of 37 542 ill returned travelers entered into the GeoSentinel Surveillance Network database Among 580 (1 5%) with VPDs common diagnoses included enteric fever (n = 276) acute viral hepatitis (n = 148) and influenza (n = 70) Factors associated with S typhi Included VFR travel (p < 0 016) to South Central Asia (p < 0 001) Business travel was associated with influenza (p < 0 001) and longer travel with hepatitis A virus (p = 0 02) 29% of those with VPDs had pre-travel consultations At least 55% of those with VPDs were managed as inpatients compared to 9 5% of those with non-VPDs Three deaths occurred one each due to pneumococcal meningitis S typhi and rabies VPDs are significant contributors to morbidity and potential mortality in travelers High rates of hospitalization make them an attractive target for pre-travel intervention (C) 2010 Elsevier Ltd All rights reserved
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available